Why DroneShield shares could rise 38%

Bell Potter thinks this growth stock could be a top buy this month.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • DroneShield shares have shot up over 400% this year, and Bell Potter thinks they can still climb higher, especially after landing a big $25.3 million contract in Latin America.
  • Counter-drone tech is getting a lot of attention in Europe due to recent drone incursions, which might speed up contracts for DroneShield.
  • Bell Potter maintains a buy rating for DroneShield, predicting a potential 38% upside with a price target of $5.30, thanks to its market-leading tech and potential big contracts looming.

DroneShield Ltd (ASX: DRO) shares may be up over 400% since the start of the year, but that doesn't necessarily mean that the run is over.

In fact, the team at Bell Potter believes the counter drone technology company's shares can still deliver outside returns for buyers over the next 12 months.

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company

Image source: Getty Images

What is the broker saying?

Bell Potter notes that the company has announced a major contract win in Latin America (LATAM) this week worth $25.3 million. This contract is significantly greater than all the previous contracts from this customer combined. It said:

DRO has announced a $25.3m contract from a defence end customer in a LATAM country. Delivery and payment is expected through 4Q25 and 1Q26. The order was received from a privately owned in-country reseller that is contractually required to distribute to a Government defence end customer in a LATAM country. DRO had previously received 7 standalone orders from this reseller between March 2019 and July 2025, totalling approx. $2.9m.

In light of this contract win, the broker has boosted its near term earnings forecasts materially and highlights that almost all its revenue estimate for FY 2025 is now accounted for. It adds:

We upgrade EPS +20% in CY25e reflecting a $10m increase in revenue following the LATAM contract award. We estimate that our $210m and $297m revenue forecasts in CY25/26e are 97% and 6% secured, respectively.

Favourable conditions

Another reason to be positive on the company's outlook is that drone incursions have continued in Europe, which emphasises the growing importance of counter drone technology. It said:

On 2/11/2025, drones were detected for a third consecutive night flying over the Kleine-Brogel military base in Belgium, adding to a growing pattern of drone incursions across Europe. These incursions highlight the need for counter-drone technology at military bases, airports and other critical infrastructure and, in our view, speeds up the signing process for European DRO contracts.

DroneShield shares tipped to rise

According to the note, broker has reaffirmed its buy rating and $5.30 price target on DroneShield shares.

Based on its latest share price of $3.83, this implies potential upside of 38% for investors over the next 12 months.

Commenting on its buy recommendation, the broker said:

We believe DRO has the market leading counter-drone offering and a strengthening competitive advantage owing to its years of experience and large R&D team, focused on detect and defeat capabilities.

We expect 2026 will be an inflection point for the global counter-drone industry with countries poised to unleash a wave of spending on soft-kill detect and defeat solutions. Consequently, we believe DRO should see material contracts flowing from its $2,550m potential sales pipeline over the next 3-6 months as defence budgets roll over to FY26.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: What this leading broker is saying about Lynas shares

Is it bullish or bearish? Let's find out.

Read more »

share buyers, investors, happy investors
Broker Notes

Bell Potter's top ASX 200 holdings revealed

These are the top holdings in the broker's core portfolio.

Read more »

An athlete runs fast with a trail of yellow smoke billowing out behind him.
Broker Notes

Up 139% in a year, why this buy rated ASX All Ords rare earths stock could keep racing higher

A leading broker forecasts more outperformance to come from this surging ASX rare earths stock.

Read more »

Miner with thumbs up at a mine.
Gold

2 ASX gold miners to buy for solid share price gains, according to Barrenjoey

The Africa-focused companies are deeply undervalued after recent sell-offs, the broker says.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »